HIKAL
Back to Income Statement
|
HIKAL Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹1,713 Cr | ₹1,860 Cr | ₹1,785 Cr | ₹2,023 Cr | ₹1,943 Cr |
What is the latest Revenue of HIKAL ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹1,713 Cr |
| Mar2025 | ₹1,860 Cr |
| Mar2024 | ₹1,785 Cr |
| Mar2023 | ₹2,023 Cr |
| Mar2022 | ₹1,943 Cr |
How is Revenue of HIKAL Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,713 Cr | -7.91 | |
| Mar2025 | ₹1,860 Cr | 4.21 | |
| Mar2024 | ₹1,785 Cr | -11.79 | |
| Mar2023 | ₹2,023 Cr | 4.13 | |
| Mar2022 | ₹1,943 Cr | - | |
Compare Revenue of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,495.6 Cr | -0.2% | -7.1% | -16.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,803.0 Cr | 0.2% | -5.2% | 4.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,833.0 Cr | 4.9% | -0.5% | 43.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,461.0 Cr | -1.1% | -8.5% | 28.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,463.0 Cr | 7.8% | 11% | 1.2% | Stock Analytics | |
| CIPLA | ₹109,870.0 Cr | 2.3% | -2.7% | -18.9% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -0.2% |
-7.1% |
-16.9% |
| SENSEX | -0.6% |
-0.5% |
-13.2% |
You may also like the below Video Courses